Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development
Marlene Tahedl,
We Fong Siah,
Jasmin Lope,
Jennifer C. Hengeveld,
Mark A. Doherty,
Russell L. McLaughlin,
Orla Hardiman,
Ee Ling Tan,
Alison Toomey,
Jana Kleinerova,
Peter Bede Annals of Neurology
· Wiley
· 2026-10-22
· DOI: 10.1002/ana.78316
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Marlene Tahedl, We Fong Siah, Jasmin Lope, Jennifer C. Hengeveld, Mark A. Doherty, Russell L. McLaughlin et al. Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development. // Annals of Neurology. – 2026. – DOI: 10.1002/ana.78316. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ana.78316?af=R
Marlene Tahedl, We Fong Siah, Jasmin Lope, Jennifer C. Hengeveld, Mark A. Doherty, Russell L. McLaughlin, Orla Hardiman, Ee Ling Tan, Alison Toomey, Jana Kleinerova, & Peter Bede (2026). Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development. Annals of Neurology. https://doi.org/10.1002/ana.78316
Marlene Tahedl, et al. “Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development.” Annals of Neurology, 2026. doi:10.1002/ana.78316.
@article{Tahedl2026,
title = {Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development},
author = {Tahedl, Marlene and Siah, We Fong and Lope, Jasmin and Hengeveld, Jennifer C. and Doherty, Mark A. and McLaughlin, Russell L. and Hardiman, Orla and Tan, Ee Ling and Toomey, Alison and Kleinerova, Jana and Bede, Peter},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78316},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ana.78316?af=R}
}